Nanolipoprotein particle (NLP) vaccine confers protection against Yersinia pestis aerosol challenge in a BALB/c mouse model.
Saved in:
| Title: | Nanolipoprotein particle (NLP) vaccine confers protection against Yersinia pestis aerosol challenge in a BALB/c mouse model. |
|---|---|
| Authors: | Biryukov SS; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Rasley A; Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.; Department of Molecular and Cell Biology, University of California, Merced, Merced, United States., Davies ML; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Klimko CP; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Dankmeyer JL; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Hunter M; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Rill NO; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Shoe JL; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Miller J; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Talyansky Y; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Sullinger B; Vaxcyte, Inc., San Carlos, CA, United States., Herrera M; Vaxcyte, Inc., San Carlos, CA, United States., Huang D; Vaxcyte, Inc., San Carlos, CA, United States., Bautista L; Vaxcyte, Inc., San Carlos, CA, United States., Pepe L; Vaxcyte, Inc., San Carlos, CA, United States., Peters SKG; Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, United States., Xander CJ; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Martinez EE; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Toothman RG; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Mlynek KD; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Bozue JA; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Qiu J; Regulated Research Administration: Biostatistics Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States., Fischer NO; Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, United States., Cote CK; Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jun 26; Vol. 16, pp. 1603710. Date of Electronic Publication: 2025 Jun 26 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1603710 |
